Unrelated to products like Juvederm, Xeomin is similar to Botox. Like Botox, Xeomin contains the botulinum toxin, which relaxes facial muscles that lead to the formation of facial wrinkles. Unlike Botox, and its counterpart Dysport, Xeomin does not contain any additives.
This means that patients that get this treatment may be less likely to develop antibodies that may negatively impact results. Xeomin was approved by the FDA in 2011 for the treatment of cervical dystonia, a neurological disorder in which the muscles of the neck and shoulders contract.
Xeomin has been approved for cosmetic indication to treat frown lines. Like Botox, physicians are able to use the medication off label to treat other areas of the face. Clinical studies indicate that Xeomin is as effective as Botox in addressing glabellar lines (frown lines) between the eyebrows.